Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village

Retrovirology

Volumn 7, Issue , 2010, Pages

  van der Loeff, Maarten F S ^a   Larke, Natasha ^b   Kaye, Steve ^a   Berry, Neil ^c   Ariyoshi, Koya ^d   Alabi, Abraham ^a   van Tienen, Carla ^a   Leligdowicz, Aleksandra ^a   Sarge Njie, Ramu ^a   da Silva, Zacharias ^e   Jaye, Assan ^a   Ricard, Dominique ^a   Vincent, Tim ^e   Jones, Sarah R ^a   Aaby, Peter ^e   Jaffar, Shabbar ^b   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d NAGASAKI UNIVERSITY   (Japan)

^e Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; AFRICA; AGED; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROSPECTIVE STUDY; RURAL AREA; SUPERINFECTION; SURVIVAL RATE; SURVIVAL TIME; VIREMIA; VIRUS LOAD; ANIMAL; BLOOD; CD4 LYMPHOCYTE COUNT; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PLASMA; PROGNOSIS; SURVIVAL; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; GUINEA-BISSAU; HIV ANTIBODIES; HIV INFECTIONS; HIV-2; HUMANS; MALE; MIDDLE AGED; PLASMA; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 77954084872     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-46     Document Type: Article

References (30)

1. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003, 100:6588-6592. 10.1073/pnas.0936469100, 164491, 12743376.
2. Rowland-Jones SL, Whittle HC. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?. Nat Immunol 2007, 8:329-331. 10.1038/ni0407-329, 17375091.
3. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, Lauritzen E. HIV-2 infection in Bissau, West Africa, 1987-1989: incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr 1993, 6:941-948.
4. da Silva ZJ, Oliveira I, Andersen A, Dias F, Rodrigues A, Holmgren B, Andersson S, Aaby P. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?. AIDS 2008, 22:1195-1202. 10.1097/QAD.0b013e328300a33d, 18525265.
5. Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ 2004, 82:462-469. 2622848, 15356940.
6. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?. AIDS 2002, 16:597-603. 10.1097/00002030-200203080-00011, 11873003.
7. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954.
8. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170. 10.1126/science.272.5265.1167, 8638160.
9. Schim van der Loeff MF, Jaffar S, Aveika AA, Sabally S, Corrah T, Harding E, Alabi A, Bayang A, Ariyoshi K, Whittle HC. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS 2002, 16:1775-1783. 10.1097/00002030-200209060-00010, 12218389.
10. Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, Ngom PT, Rolfe M, Wilkins A. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994, 8:1617-1620. 10.1097/00002030-199411000-00015, 7848600.
11. Holmgren B, da Silva Z, Vastrup P, Larsen O, Andersson S, Ravn H, Aaby P. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007, 4:85. 10.1186/1742-4690-4-85, 2222662, 18042276.
12. Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, Lisse IM, Christiansen CB, Dias F, Melbye M. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997, 349:911-914. 10.1016/S0140-6736(96)04402-9, 9093252.
13. Berry N, Ariyoshi K, Jaffar S, Sabally S, Corrah T, Tedder R, Whittle H. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1998, 1:457-468.
14. Jaffar S, Wilkins A, Ngom PT, Sabally S, Corrah T, Bangali JE, Rolfe M, Whittle HC. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:327-332.
15. Lisse IM, Poulsen AG, Aaby P, Knudsen K, Dias F. Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:355-362.
16. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590. 10.1126/science.7915856, 7915856.
17. Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, Awasana AA, Corrah T, Sabally S, Sarge-Njie R, Cham-Jallow F, Jaye A, Berry N, Whittle H. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 2003, 17:1513-1520. 10.1097/00002030-200307040-00012, 12824789.
18. Hansmann A, Schim van der Loeff MF, Kaye S, Awasana AA, Sarge-Njie R, O'Donovan D, Ariyoshi K, Alabi A, Milligan P, Whittle HC. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia. J Acquir Immune Defic Syndr 2005, 38:335-341.
19. Jaffar S, Loeff MS, Eugen-Olsen J, Vincent T, Sarje-Njie R, Ngom P, Meyer AM, Berry N, Aaby P, Whittle H. Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. AIDS Res Hum Retroviruses 2005, 21:560-564. 10.1089/aid.2005.21.560, 15989461.
20. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, Dias F, Wilkins A, Ricard D, Aaby P, Tedder R, Whittle H. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses 2002, 18:1167-1173. 10.1089/08892220260387904, 12487822.
21. Wilkins A, Ricard D, Todd J, Whittle H, Dias F, Paulo Da Silva A. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS 1993, 7:1119-1122. 10.1097/00002030-199308000-00015, 8397950.
22. Ricard D, Wilkins A, N'Gum PT, Hayes R, Morgan G, Da Silva AP, Whittle H. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994, 8:977-982. 10.1097/00002030-199407000-00016, 7946109.
23. Leligdowicz A, Yindom LM, Onyango C, Sarge-Njie R, Alabi A, Cotten M, Vincent T, da Costa C, Aaby P, Jaye A, et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007, 117:3067-3074. 10.1172/JCI32380, 1964515, 17823657.
24. O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, Whittle H. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000, 14:441-448. 10.1097/00002030-200003100-00019, 10770548.
25. O'Brien TR, Rosenberg PS, Yellin F, Goedert JJ. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:155-161.
26. Ariyoshi K, Cham F, Berry N, Jaffar S, Sabally S, Corrah T, Whittle H. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 1995, 9:555-559. 10.1097/00002030-199506000-00004, 7662192.
27. Keele BF, Jones JH, Terio KA, Estes JD, Rudicell RS, Wilson ML, Li Y, Learn GH, Beasley TM, Schumacher-Stankey J, Wroblewski E, Mosser A, Raphael J, Kamenya S, Lonsdorf EV, Travis DA, Mlengeya T, Kinsel MJ, Else JG, Silvestri G, Goodall J, Sharp PM, Shaw GM, Pusey AE, Hahn BH. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009, 460:515-519. 10.1038/nature08200, 2872475, 19626114.
28. Yindom LM, Leligdowicz A, Martin MA, Gao X, Qi Y, Zaman A, Schim van der Loeff M, van Tienen C, Jaye A, Aveika AA, et al. HLA class and HLA-KIR compound genotypes predict HIV-2 infection and disease progression in a manjako community in Caio, Guinea Bissau. J Virol 2009,
29. Grassly NC, Xiang Z, Ariyoshi K, Aaby P, Jensen H, Schim van der Loeff M, Dias F, Whittle H, Breuer J. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. J Virol 1998, 72:7895-7899. 110115, 9733826.
30. Onyango C, Leligdowicz A, Yokoyma M, Sato H, Song H, Nakayama E, Shioda T, De Silva T, Townend J, Jaye A, et al. HIV-2 capsids distinguish high and low virus load patients in a West African Community Cohort. Vaccine 2010,